Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Chugai Pharmaceutical Co., Ltd. (OTC: CHGCY).

Full DD Report for CHGCY

You must become a subscriber to view this report.


Recent News from (OTC: CHGCY)

Chugai Pharmaceutical Co., Ltd. ADR 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: April, 25 2018 14:07
Week In Review: James Watson To Lead New Shenzhen Biopharma Research Center
Industry Developments James Watson, who co-discovered the double-helix structure of DNA in 1953, will lead a new international life science research center in the International Bio Valley, located in Shenzhen's Dapeng New Area. A groundbreaking ceremony was held last Friday with Dr. Watson i...
Source: SeekingAlpha
Date: March, 25 2018 09:31
Chugai Pharmaceutical Co., Ltd. ADR 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: February, 02 2018 14:12
Books will close today December 29, 2017.
Books will close today December 29, 2017.
Source: OTC Markets
Date: December, 29 2017 00:00
Chugai Pharmaceutical Co., Ltd. ADR 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2017 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 25 2017 14:24
Roche: Buying The Dip
Introduction Roche Holding ( RHHBY ), based in Switzerland, controls 100% of the world's largest and most prominent biotech firm, Genentech; and all of the world's largest diagnostic company. The latter generates about 22% of RHHBY's sales. Depending on currency translations between the S...
Source: SeekingAlpha
Date: October, 25 2017 11:42
Chugai Pharmaceutical (CHGCY) Presents R&D Conference Call - Slideshow
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: July, 12 2017 12:42
Books will close today June 28th, 2017.
Books will close today June 28th, 2017.
Source: OTC Markets
Date: June, 28 2017 00:00
PharmaMar and Chugai ink license deal for cancer candidate PM1183 in Japan
Spanish pharma outfit PharmaMar S.A. enters into an exclusive license, development and commercialization agreement with Chugai Pharmaceutical ( OTC:CHGCF )( OTCPK:CHGCY ) for its third marine-derived cancer candidate PM1183 (lurbinectedin). More news on: Chugai Pharmaceutical Co., Ltd., ...
Source: SeekingAlpha
Date: December, 22 2016 08:07
PharmaMar and Chugai Pharmaceutical Enter into a License and Commercialization Agreement for PM1183 in Japan
MADRID and TOKYO , December 22, 2016 /PRNewswire/ -- PharmaMar (MCE: PHM) has announced today the signing of an exclusive license, development and commercialization agreement with Chugai Pharmaceutical Co. Ltd. (TSE: 4519) for its third marine-derived anticancer drug PM1183 (lurbinect...
Source: PR Newswire
Date: December, 22 2016 03:24

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-07-20N/A102.00N/AN/A0
2018-07-19N/A102.00N/AN/A0
2018-07-18N/A102.00N/AN/A0
2018-07-17N/A102.00N/AN/A0
2018-07-16N/A102.00N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-07-061001,3177.5930Cover
2018-04-30355985.8528Cover
2018-04-2430963648.5849Short
2018-04-165001,74828.6041Cover
2018-03-2644100.0000Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CHGCY.


About Chugai Pharmaceutical Co., Ltd. (OTC: CHGCY)

Logo for Chugai Pharmaceutical Co., Ltd. (OTC: CHGCY)

Chugai Pharma Manufacturing Co., Ltd. is commissioned to manufacture pharmaceuticals.

 

Contact Information

 

 

Current Management

  • Motoo Ueno / Deputy Chairman
  • Osamu Nagayama / CEO
  • Tatsuro Kosaka / President, COO
  • Osamu Nagayama / Chairman
  • Yoshio Itaya /
  • Tatsumi Yamazaki /

Current Share Structure

  • Market Cap: $28,824,035,000 - 03/09/2018
  • Issue and Outstanding: 559,690,000 - 02/28/2013

 



Daily Technical Chart for (OTC: CHGCY)

Daily Technical Chart for (OTC: CHGCY)


Stay tuned for daily updates and more on (OTC: CHGCY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CHGCY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CHGCY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CHGCY and does not buy, sell, or trade any shares of CHGCY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/